Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation

NCT03300687 is registered in ClinicalTrials.gov with Frequency Therapeutics as lead sponsor.

NCT NCT03300687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03300687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation
Lead sponsor
Frequency Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
May 30, 2017
Completion date
January 18, 2018
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hearing loss